Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2011
04/27/2011CN101492460B Benzimidazole derivative containing alkoxyl oxygen alkyl substituted pyridine-tetrahydrochysene isoxazole
04/27/2011CN101492459B Compound containing alcoxyl acetyl dihydrogen isoxazole-pyridine
04/27/2011CN101491514B Use of phenylalanine derivative in preparing anti-hepatic-B virus medicine
04/27/2011CN101485677B Application of medlar polysaccharide in preventing urinary calculus
04/27/2011CN101474242B Medicament for treating cervical vertebra and lumbar vertebra diseases without operation
04/27/2011CN101474151B Alkannin microemulsion composition
04/27/2011CN101468991B Isoquinolinium compound or its salt, pharmaceutical composition containing the same, preparation and use thereof
04/27/2011CN101461813B Cefotiam hydrochloride preparation for injection and preparation method thereof
04/27/2011CN101455771B External traditional Chinese medicine ointment for treating hemorrhoid
04/27/2011CN101448498B Compositions of r(+) and s(-) pramipexole and methods of using the same
04/27/2011CN101439091B Agent for nursing eye skin by eliminating and alleviating cell fatigue of eye skin
04/27/2011CN101428003B Preparation of RGDF-fatty alcohol couplet mediated adriablastina target lipid and uses as anti-tumour agents
04/27/2011CN101423539B 4'',11-diamino formic ether azithromycin derivates, preparation method and medicament composition thereof
04/27/2011CN101422471B Use of prunol glycoside and plant extract containing the same
04/27/2011CN101422432B Preparation method of tilmicosin nano-emulsion antibacterial drug
04/27/2011CN101422430B Ketoconazole m-thymol liquor for treating skin tinea
04/27/2011CN101418015B Ceftriaxone phosphorylation derivates
04/27/2011CN101418001B Dipeptidase-IV inhibitor sulfonyl urea derivates
04/27/2011CN101417988B Biguanide piperazines dipeptidyl peptidase IV inhibitor
04/27/2011CN101412718B Carbapenem derivative containing sulfenyl heterocyclic amine formyl
04/27/2011CN101411700B Use of 5,7,4'-trihydroxy flavanone or derivative thereof for analgesia
04/27/2011CN101406566B Chinese medicine for treating gastric cancer
04/27/2011CN101406513B Malaytea scurfpea fruit extract, pharmaceutical composition containing the same, and preparation method and application thereof
04/27/2011CN101397300B Dipeptidase-IV inhibitor derivates
04/27/2011CN101396351B Drug-loaded polyelectrolyte capsules in response to phosphatase concentration and preparation method thereof
04/27/2011CN101391061B Novel antibiotic substitute
04/27/2011CN101374831B Tetrahydropyrane antibiotics
04/27/2011CN101371899B Medicine for treating tympanitis
04/27/2011CN101370805B Novel pyridine derivatives
04/27/2011CN101367812B Sulfhydryl pyrrolidine formamido cyclopentene acid substituted penem derivant
04/27/2011CN101367809B Penem derivant containing sulfhydryl pyrrolidine formhydrazide
04/27/2011CN101362722B N-substituted phenyl-2-(1-aryl-1H-imidazolyl-2-sulfhydryl) acetamides derivates, preparation method thereof and application
04/27/2011CN101361804B Enteral nutrition emulsion for tumor patient
04/27/2011CN101342406B Magnetic health care instrument for treating cervical vertebra, lumbar and shoulder ache
04/27/2011CN101333529B SiRNA sequence against HCMV UL122 gene and applications
04/27/2011CN101333527B SiRNA sequence of human cytomegalovirus UL122 gene and applications
04/27/2011CN101333525B SiRNA sequence against HCMV UL86 gene and applications
04/27/2011CN101323616B Carbpenem derivates containing sulfhydryl thiazole
04/27/2011CN101318980B Dicaryon platinum containing complex, preparation method and application thereof
04/27/2011CN101318948B Lubiprostone1 crystal, preparation method and uses thereof
04/27/2011CN101313944B Herbal pain penetrating fluid
04/27/2011CN101307056B Linear furocoumarin derivates, preparation method and application thereof, pharmaceutical compositions containing the derivates
04/27/2011CN101297870B Uses of Macleaya cordata total alkaloids or salts thereof for resisting liver fibrosis due to schistosomiasis
04/27/2011CN101297858B Oral liquid for treating infection by avian viruses mixed with salmonella and preparation
04/27/2011CN101292958B Method of preparing ultra-fine danazol powder
04/27/2011CN101288642B Taxanes medicine preparation for intravenous injection and preparation method thereof
04/27/2011CN101284828B Cycloheptapyridine compounds, preparation method thereof, use and pharmaceutical compositions containing the compounds
04/27/2011CN101284036B Medicine for treating injured sinews or bones and preparation method thereof
04/27/2011CN101274927B Photochemical reaction preparation for quaternary ring compound and use of the quaternary ring compound
04/27/2011CN101269059B Isosorbide dinitrate oral administration impulse pellet preparations
04/27/2011CN101267818B Uses of amino acid and amino acid supplements thereof
04/27/2011CN101250181B S-泮托拉唑钠 S- pantoprazole sodium
04/27/2011CN101247800B Anti-allergic agent
04/27/2011CN101244129B Lhasa rhubarb extract, preparation method, and application in preparing preparation for treating cardiovascular and cerebrovascular diseases
04/27/2011CN101235038B Use of glycyrol in preparing immunity inhibitor
04/27/2011CN101225093B Aminoglycoside derivatives
04/27/2011CN101219985B N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
04/27/2011CN101209109B Composition with muscle-increasing function and beverage prepared thereby
04/27/2011CN101204439B Pain-alleviating adhesive plaster of rose and Preparation method thereof
04/27/2011CN101199623B Preparing method for treating hypertension drug slow controlled-release preparation
04/27/2011CN101198608B Prodrugs of A2b adenosine receptor antagonists
04/27/2011CN101190890B 5-[(2R)-[2-[2-[2-(2,2,2-trifluoroethoxyl)phenoxyl]ethyl]amino]propyl]-2-methoxylbenzsulfamide
04/27/2011CN101190282B Sugar-free compound traditional Chinese medicinal preparation for treating upper respiratory tract infection and quality control method thereof
04/27/2011CN101180298B New antibiotic derivatives
04/27/2011CN101167933B Composite medicine for treating rheumatic diseases
04/27/2011CN101161668B Application of flavone c-glycosides in preparation of drugs curing and preventing hepatitis
04/27/2011CN101143192B Therapeutic gastrodia extracts
04/27/2011CN101134057B Compound medicament of natural plant extract containing paclitaxel and anticancer application thereof
04/27/2011CN101132798B Application of nucleic acid molecule in preparing medicine for treatment of neoplasms and composition
04/27/2011CN101129908B Antitussive of Miao national herbs bile prime and method of preparing bile prime
04/27/2011CN101113149B Aliphatic organic acid salt of berberine type alkaloid and preparation method and usage thereof
04/27/2011CN101111244B Composition for promoting production of hyaluronic acid containing kaempferol and quercetin
04/27/2011CN101103020B Cgrp receptor antagonists
04/27/2011CN101092417B Folacin analogue, and salt of folacin analogue in use for medical treatment
04/27/2011CN101092415B Compound of new benzo heterocycle categories, preparation method and application
04/27/2011CN101085297B Traditional Chinese medicine freeze dried injection for curing cerebral infarction and preparation method thereof
04/27/2011CN101084862B Compositions containing a hydroxylated diphenylmethane compound
04/27/2011CN101068533B Pharmaceutical composition containing an anti-nucleating agent
04/27/2011CN101049355B Composition of medication prepared from safflower and leaves of hawthorn
04/27/2011CN101049315B Formula for medicine for common acne
04/27/2011CN101036654B Stable cefoperazone sulbactam medicine compound preparation
04/27/2011CN101033224B Novel pyrimidines small molecular compound, its preparation method and use
04/27/2011CN101006846B Anti-stress nutrition additives for poultry and its preparation method
04/26/2011US7932405 Anticoagulants based on halogenated warfarin analogs; side effect reduction; e.g. 2,2,3,3,3-pentafluoropropyl 3-(4-hydroxy-2-oxo-2H-chromen-3-yl)-3-phenylpropanoate
04/26/2011US7932401 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant
04/26/2011US7932399 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
04/26/2011US7932395 Substituted 1H-dihydropyrazoles, their preparation and use
04/26/2011US7932394 1-{[5-[4-(Methylsulfonyl)phenoxy]-2-(2-pyridinyl)-1H-benzimidazol-6-yl]methyl}-5-thioxo-2-pyrrolidinone;glucokinase activator; antidiabetic agents; obesity; prevention of retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis; antiischemic agents; cardiotonic agents
04/26/2011US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
04/26/2011US7932390 Substituted thieno[3,2-C]pyridine carboxylic acid derivatives
04/26/2011US7932387 Crystalline forms of rosuvastatin calcium salt
04/26/2011US7932384 Reverse-turn mimetics and method relating thereto
04/26/2011US7932383 Crystalline forms of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
04/26/2011US7932382 Amide substituted heterocylic compound; anticarcinogen; inducing apoptotic cell death, sensitizing cells to inducers of apoptosis
04/26/2011US7932377 Complexing of medicinal substances with high-molecular carriers and injection and infusion solutions containing said complexes
04/26/2011US7932376 Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
04/26/2011US7932373 Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
04/26/2011US7932367 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
04/26/2011US7932294 Prodrugs containing novel bio-cleavable linkers
04/26/2011US7932291 Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use